Computationally accelerated identification of P-glycoprotein inhibitors
PLOS One · 2025
DOI: 10.1371/journal.pone.0325121 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Lauren A McCormick und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Southern Methodist University, Dallas, Texas, United States of America. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 1, Drug Discovery, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health's (NIH) National Institute of General Medical Sciences.
Abstract (Originalsprache)
Overexpression of the polyspecific efflux transporter, P-glycoprotein (P-gp, MDR1, ABCB1 ), is a major mechanism by which cancer cells acquire multidrug resistance (MDR), the resistance to diverse chemotherapeutic drugs. Inhibiting drug transport by P-gp can resensitize cancer cells to chemotherapy, but there are no P-gp inhibitors available to patients. Clinically unsuccessful P-gp inhibitors tend to bind at the pump’s transmembrane drug binding domains and are often P-gp transport substrates, resulting in lowered intracellular concentration of the drug and altered pharmacokinetics. In prior work, we used computationally accelerated drug discovery to identify novel P-gp inhibitors that target the pump’s cytoplasmic nucleotide binding domains. Our first-draft study provided conclusive evidence that the nucleotide binding domains of P-gp are viable targets for drug discovery. Here we develop an enhanced, computationally accelerated drug discovery pipeline that expands upon our prior work by iteratively screening compounds against multiple conformations of P-gp with molecular docking. Targeted molecular dynamics simulations with our homology model of human P-gp were used to generate docking receptors in conformations mimicking a putative drug transport cycle. We offset the increased computational complexity using custom Tanimoto chemical datasets, which maximize the chemical diversity of ligands screened by docking. Using our expanded, virtual-assisted pipeline, we identified nine novel P-gp inhibitors that reverse MDR in two types of P-gp overexpressing human cancer cell lines, reflecting a 13.4% hit rate. Of these inhibitors, all were non-toxic to non-cancerous human cells, and six were not likely to be transport substrates of P-gp. Our novel P-gp inhibitors are chemically diverse and are good candidates for lead optimization. Our results demonstrate that the nucleotide binding domains of P-gp are an underappreciated target in the effort to reverse P-gp-mediated multidrug resistance in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Southern Methodist University, Dallas, Texas, United States of America.
- Center for Drug Discovery, Design and Delivery, Southern Methodist University, Dallas, Texas, United States of America.
- Center for Scientific Computation, Southern Methodist University, Dallas, Texas, United States of America.
ORCID-Profile: Lauren A McCormick
Förderung
- NIGMS NIH HHS
- National Institutes of Health's (NIH) National Institute of General Medical Sciences
Zitieren
APA
McCormick, L. A., McCormick, J. W., Park, C., Follit, C. A., Wise, J. G., & Vogel, P. D. (2025). Computationally accelerated identification of P-glycoprotein inhibitors. PLOS One. https://doi.org/10.1371/journal.pone.0325121
Vancouver
McCormick LA, McCormick JW, Park C, Follit CA, Wise JG, Vogel PD. Computationally accelerated identification of P-glycoprotein inhibitors. PLOS One. 2025. doi:10.1371/journal.pone.0325121
BibTeX
@article{McCormick2025,
author = {McCormick, Lauren A and McCormick, James W and Park, Chanyang and Follit, Courtney A and Wise, John G and Vogel, Pia D},
title = {Computationally accelerated identification of P-glycoprotein inhibitors},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325121}
}
EUVIMED